ekei labs
1 known investors
ekei labs offers genome-wide DNA methylation sequencing using a proprietary non-destructive enzymatic method, paired with indication-specific AI/ML models to interpret epigenetic data from blood, cells, tissue, and saliva. It serves drug developers and cell/product manufacturers for target discovery, biomarker development, and quality control, and offers a cell test kit that estimates biological age.